Environmental Test Bundle (Mold Exposure, Toxic Non-Metal Chemicals, Glyphosate)-Urine
Bundle includes: MycoTox Profile (Mold Exposure), GPL-TOX Profile (172 Toxic Non-Metal Chemicals), and Glyphosate Test
The Great Plains Laboratory Environmental Test Bundle includes the MycoTOX Profile (Mold Exposure), GPL-TOX Profile (172 Toxic Non-Metal Chemicals), and Glyphosate Test.
- MycoTox Profile (Mold Exposure)-First morning void urine sample. Test brochure
- GPL-TOX Profile (172 Toxic Non-Metal Chemicals)-First morning void urine sample. Test brochure
- Glyphosate Test-First morning void urine sample. Test brochure
Turnaround time for results is 2-4 weeks from the time a specimen is received.
All Orders Receive:
- Test kits shipped directly to the address provided.
- Step-by-step test collection instructions.
- Email support from IOE Program within 24 hours to confirm shipping address.
- Prepaid shipping label for the submission of a sample.
- Written report that summarizes all test findings emailed to you as a PDF file.
- The option to receive additional insight into these findings by Dr. Lawenda. **Requires additional purchase of a lab review. Not automatically included.
**NEW YORK RESIDENTS: Restrictions apply. If you are interested in this test, please reach out to us by emailing email@example.com before ordering.
**INTERNATIONAL ORDERS: Restrictions apply. Please contact us to confirm availability by emailing firstname.lastname@example.org. Testing not available in all areas outside of U.S.**
MYCOTOX PROFILE (Mold Exposure)
Mycotoxins are some of the most prevalent toxins in the environment. Mycotoxins are metabolites produced by fungi like mold, which can infest buildings, vehicles, and foodstuffs. A majority of mycotoxin exposures are through food ingestion or airborne exposure. In the European Union, 20% of all grains harvested have been found to be contaminated with mycotoxins. Unfortunately, mycotoxins are resistant to heat and many processing procedures.
Fungi are able to grow on almost any surface, especially if the environment is warm and wet. Inner wall materials of buildings, wall paper, fiber glass insulation, ceiling tiles, and gypsum support are all good surfaces for fungi to colonize. These fungi then release mycotoxins into the environment causing symptoms of many different chronic diseases. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. With our new MycoTOX Profile, we can identify mycotoxin exposures and make recommendations for detoxification treatments that have been effective.
ADVANTAGES OF THE MYCOTOX PROFILE:
- MycoTOX screens for eleven different mycotoxins, from 40 species of mold, in one urine sample.
- MycoTOX is the most comprehensive and competitively priced mycotoxin test available.
- MycoTOX uses the power of advanced mass spectrometry (MS/MS), which is necessary to detect lower levels of these fungal toxins. This test is optimal for follow up testing to ensure that detoxification therapies have been successful.
- MycoTOX pairs perfectly with the Organic Acids Test (OAT), GPL-TOX (Toxic Non-Metal Chemical Profile), Phospholipase A2 Activity Test, and the Glyphosate Test. This gives you comprehensive testing to assess exposure to common environmental toxins and the damage that can be caused by this exposure, all at a great value, and all from one urine sample.
Why Is This Test Important?
Virtually every neurological disease has been associated with mycotoxin exposure: autism, Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson’s disease. There is a strong association between mycotoxin exposure and cancers, especially liver and kidney cancers. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, nose bleeding, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. A study of patients with chronic fatigue found that all the patients had high levels of mycotoxins in the urine.
GPL-TOX PROFILE (172 Toxic Non-Metal Chemicals)
Every day, we are exposed to hundreds of toxic chemicals through products like pharmaceuticals, pesticides, packaged foods, household products, and environmental pollution. As we have become more exposed to chemical-laden products and to toxic chemicals in food, air, and water, we have been confronted with an accelerating rate of chronic illnesses like cancer, heart disease, chronic fatigue syndrome, chemical sensitivity, autism spectrum disorders, ADD/AD(H)D, autoimmune disorders, Parkinson’s disease, and Alzheimer’s disease.
Because exposure to environmental pollutants has been linked to many chronic diseases, The Great Plains Laboratory has created GPL-TOX, a toxic non-metal chemical profile that screens for the presence of 173 different toxic chemicals including organophosphate pesticides, phthalates, benzene, xylene, vinyl chloride, pyrethroid insecticides, acrylamide, perchlorate, diphenyl phosphate, ethylene oxide, acrylonitrile, and more. This profile also includes Tiglylglycine (TG), a marker for mitochondrial disorders resulting from mutations of mitochondrial DNA. These mutations can be caused by exposure to toxic chemicals, infections, inflammation, and nutritional deficiencies.
ADVANTAGES OF THE GPL-TOX PROFILE
- GPL-TOX screens for 173 different environmental pollutants using 18 different metabolites, all from a single urine sample.
- GPL-TOX uses the power of advanced mass spectrometry (MS/MS), which is necessary to detect lower levels of certain genetic, mitochondrial, and toxic chemical markers that conventional mass spectrometry often misses.
- GPL-TOX also includes Tiglylglycine, a marker for mitochondrial damage, which is often seen in chronic toxic chemical exposure.
GPL-TOX IS RECOMMENDED FOR THE FOLLOWING DISORDERS:
- Alzheimer’s Disease
- Amyotrophic Lacteroclerosis (ALS)
- Anorexia Nervosa
- Anxiety Disorder
- Attention deficit (ADD)
- Attention deficit with hyperactivity (ADHD)
- Autoimmune disorders
- Bipolar disorder
- Cerebral palsy
- Chronic fatigue syndrome
- Crohn’s disease
- Developmental disorder
- Down Syndrome
- Failure to thrive
- Genetic diseases
- Irritable bowel syndrome
- Learning disability
- Mitochondria disorder
- Multiple sclerosis
- Obsessive compulsive disorder (OCD)
- Occupational exposures
- Parkinson’s disease
- Peripheral neuropathy
- Seizure disorders
- Systemic lupus erythematosus
- Tic disorders
- Tourette syndrome
- Ulcerative colitis
Glyphosate is the world’s most widely produced herbicide and is the primary toxic chemical in Roundup™, as well as in many other herbicides. In addition, it is a broad-spectrum herbicide that is used in more than 700 different products from agriculture and forestry to home use. Glyphosate was introduced in the 1970s to kill weeds by targeting the enzymes that produce the amino acids tyrosine, tryptophan, and phenylalanine. The enzymes of many bacteria are also susceptible to inhibition by this chemical, thus altering the flora of many animals. Usage of glyphosate has since amplified, after the introduction of genetically modified (GMO) glyphosate-resistant crops that can grow well in the presence of this chemical in soil. In addition, toxicity of the surfactant commonly mixed with glyphosate, polyoxyethyleneamine (POEA), is greater than the toxicity of glyphosate alone. In addition, in 2014 Enlist Duo™, a herbicide product which contains a 2,4-dichlorophenoxyacetic acid (2,4-D) salt and glyphosate, was approved for use in Canada and the U.S. for use on genetically modified soybeans and genetically modified maize, both of which were modified to be resistant to both 2,4-D and glyphosate. 2,4-D has many toxic effects of its own and can be
Why Is This Test Important?
High correlations exist between glyphosate usage and numerous chronic illnesses, including autism. Other disease incidences with high correlations include hypertension, stroke, diabetes , obesity, lipoprotein metabolism disorder, Alzheimer’s, senile dementia, Parkinson’s, multiple sclerosis, inflammatory bowel disease, intestinal infections, end stage renal disease, acute kidney failure, cancers of the thyroid, liver, bladder, pancreas, kidney, and myeloid leukemia. Correlations are not causations, yet they raise concern over the use of a chemical to which all life on earth appears to be exposed.